The effect of recombinant IgG antibodies against the leucine-33 form of the platelet β3 integrin (HPA-1a) on platelet function

Summary Recombinant HPA-1a antibodies with Fc, mutated to remove destructive effector functions, have been developed as a potential therapy for fetomaternal alloimmune thrombocytopenia (FMAIT), via blockade of binding of human HPA-1a polyclonal antibodies to fetal HPA-1a1b platelets. We have assesse...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thrombosis and haemostasis 2004, Vol.91 (4), p.743-754
Hauptverfasser: Joutsi-Korhonen, Lotta, Preston, Sandy, Smethurst, Peter A., IJsseldijk, Martin, Schaffner-Reckinger, Elisabeth, Armour, Kathryn L., Watkins, Nicholas A., Clark, Michael R., de Groot, Philip G., Farndale, Richard W., Ouwehand, Willem H., Williamson, Lorna M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!